🇱🇺 Luxembourg
Luxembourg introduced its medical cannabis law on 20 July 2018, with the programme officially commencing in February 2019. Under the country’s medical cannabis programme, only doctors licensed in Luxembourg and those who have specific training for its prescription may prescribe medical cannabis to patients.
Medical cannabis is dispensed at hospital pharmacies and is covered by public health insurance.
Medical cannabis may be prescribed to patients who suffer from:
- Serious chronic diseases - classified as long-term diseases under Article 19b(1) of the Social Security Code, which are in an advanced or terminal stage and result in severe and disabling chronic pain. Patient must also have exhausted all available drug treatments, or where such treatments are not available.
- Nausea & Vomiting - due to cancer treatment through chemotherapy
- Symptomatic muscle spasticity - associated to Multiple Sclerosis
As of 1 January 2025, high-THC flowers have been removed as prescribable medical cannabis, thereby limiting the roughly 1,100 medical cannabis patients to balanced and high CBD flower products and cannabis oil extracts (High THC, Balanced, High CBD). The removal of high THC flowers is part of longer-term plans to phase out flower-based products altogether.
On 6 January 2025, it was announced that Tilray Deutschland GmbH was awarded the tender to supply a maximum quantity of 100 kilograms of cannabis flower tops.